Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Helminthic Infestations Therapeutics Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Helminthic Infestations Therapeutics Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Helminthic Infestations Therapeutics Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type
    • 1.4.2 Benzimidazole
    • 1.4.3 Pyrantel
    • 1.4.4 Piperazine Citrate
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Application
    • 1.5.2 Enterobius vermicularis
    • 1.5.3 Taenia saginata
    • 1.5.4 Ascaris lumbricoides
    • 1.5.5 Trichuris trichiura
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Helminthic Infestations Therapeutics Market Size, Estimates and Forecasts
    • 2.1.1 Global Helminthic Infestations Therapeutics Revenue 2015-2026
    • 2.1.2 Global Helminthic Infestations Therapeutics Sales 2015-2026
  • 2.2 Global Helminthic Infestations Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Helminthic Infestations Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Helminthic Infestations Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Helminthic Infestations Therapeutics Competitor Landscape by Players

  • 3.1 Helminthic Infestations Therapeutics Sales by Manufacturers
    • 3.1.1 Helminthic Infestations Therapeutics Sales by Manufacturers (2015-2020)
    • 3.1.2 Helminthic Infestations Therapeutics Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Helminthic Infestations Therapeutics Revenue by Manufacturers
    • 3.2.1 Helminthic Infestations Therapeutics Revenue by Manufacturers (2015-2020)
    • 3.2.2 Helminthic Infestations Therapeutics Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Helminthic Infestations Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Helminthic Infestations Therapeutics Revenue in 2019
    • 3.2.5 Global Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Helminthic Infestations Therapeutics Price by Manufacturers
  • 3.4 Helminthic Infestations Therapeutics Manufacturing Base Distribution, Product Types
    • 3.4.1 Helminthic Infestations Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Helminthic Infestations Therapeutics Product Type
    • 3.4.3 Date of International Manufacturers Enter into Helminthic Infestations Therapeutics Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Helminthic Infestations Therapeutics Market Size by Type (2015-2020)
    • 4.1.1 Global Helminthic Infestations Therapeutics Sales by Type (2015-2020)
    • 4.1.2 Global Helminthic Infestations Therapeutics Revenue by Type (2015-2020)
    • 4.1.3 Helminthic Infestations Therapeutics Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Helminthic Infestations Therapeutics Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Helminthic Infestations Therapeutics Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Helminthic Infestations Therapeutics Revenue Forecast by Type (2021-2026)
    • 4.2.3 Helminthic Infestations Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Helminthic Infestations Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Helminthic Infestations Therapeutics Market Size by Application (2015-2020)
    • 5.1.1 Global Helminthic Infestations Therapeutics Sales by Application (2015-2020)
    • 5.1.2 Global Helminthic Infestations Therapeutics Revenue by Application (2015-2020)
    • 5.1.3 Helminthic Infestations Therapeutics Price by Application (2015-2020)
  • 5.2 Helminthic Infestations Therapeutics Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Helminthic Infestations Therapeutics Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Helminthic Infestations Therapeutics Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Helminthic Infestations Therapeutics Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Helminthic Infestations Therapeutics by Country
    • 6.1.1 North America Helminthic Infestations Therapeutics Sales by Country
    • 6.1.2 North America Helminthic Infestations Therapeutics Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Helminthic Infestations Therapeutics Market Facts & Figures by Type
  • 6.3 North America Helminthic Infestations Therapeutics Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Helminthic Infestations Therapeutics by Country
    • 7.1.1 Europe Helminthic Infestations Therapeutics Sales by Country
    • 7.1.2 Europe Helminthic Infestations Therapeutics Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Helminthic Infestations Therapeutics Market Facts & Figures by Type
  • 7.3 Europe Helminthic Infestations Therapeutics Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Helminthic Infestations Therapeutics by Region
    • 8.1.1 Asia Pacific Helminthic Infestations Therapeutics Sales by Region
    • 8.1.2 Asia Pacific Helminthic Infestations Therapeutics Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Helminthic Infestations Therapeutics Market Facts & Figures by Type
  • 8.3 Asia Pacific Helminthic Infestations Therapeutics Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Helminthic Infestations Therapeutics by Country
    • 9.1.1 Latin America Helminthic Infestations Therapeutics Sales by Country
    • 9.1.2 Latin America Helminthic Infestations Therapeutics Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Helminthic Infestations Therapeutics Market Facts & Figures by Type
  • 9.3 Central & South America Helminthic Infestations Therapeutics Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Helminthic Infestations Therapeutics by Country
    • 10.1.1 Middle East and Africa Helminthic Infestations Therapeutics Sales by Country
    • 10.1.2 Middle East and Africa Helminthic Infestations Therapeutics Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Helminthic Infestations Therapeutics Market Facts & Figures by Type
  • 10.3 Middle East and Africa Helminthic Infestations Therapeutics Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Neural Analytics, Inc.
    • 11.1.1 Neural Analytics, Inc. Corporation Information
    • 11.1.2 Neural Analytics, Inc. Description and Business Overview
    • 11.1.3 Neural Analytics, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Neural Analytics, Inc. Helminthic Infestations Therapeutics Products Offered
    • 11.1.5 Neural Analytics, Inc. Related Developments
  • 11.2 M3 Biotechnology, Inc.
    • 11.2.1 M3 Biotechnology, Inc. Corporation Information
    • 11.2.2 M3 Biotechnology, Inc. Description and Business Overview
    • 11.2.3 M3 Biotechnology, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Products Offered
    • 11.2.5 M3 Biotechnology, Inc. Related Developments
  • 11.3 Cerevance
    • 11.3.1 Cerevance Corporation Information
    • 11.3.2 Cerevance Description and Business Overview
    • 11.3.3 Cerevance Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Cerevance Helminthic Infestations Therapeutics Products Offered
    • 11.3.5 Cerevance Related Developments
  • 11.4 Mitochon Pharmaceuticals, Inc.
    • 11.4.1 Mitochon Pharmaceuticals, Inc. Corporation Information
    • 11.4.2 Mitochon Pharmaceuticals, Inc. Description and Business Overview
    • 11.4.3 Mitochon Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Products Offered
    • 11.4.5 Mitochon Pharmaceuticals, Inc. Related Developments
  • 11.5 Peptilogics
    • 11.5.1 Peptilogics Corporation Information
    • 11.5.2 Peptilogics Description and Business Overview
    • 11.5.3 Peptilogics Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Peptilogics Helminthic Infestations Therapeutics Products Offered
    • 11.5.5 Peptilogics Related Developments
  • 11.6 Farmoquimica S/A
    • 11.6.1 Farmoquimica S/A Corporation Information
    • 11.6.2 Farmoquimica S/A Description and Business Overview
    • 11.6.3 Farmoquimica S/A Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Farmoquimica S/A Helminthic Infestations Therapeutics Products Offered
    • 11.6.5 Farmoquimica S/A Related Developments
  • 11.7 biOasis Technologies, Inc.
    • 11.7.1 biOasis Technologies, Inc. Corporation Information
    • 11.7.2 biOasis Technologies, Inc. Description and Business Overview
    • 11.7.3 biOasis Technologies, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Products Offered
    • 11.7.5 biOasis Technologies, Inc. Related Developments
  • 11.8 HCA Healthcare, Inc.
    • 11.8.1 HCA Healthcare, Inc. Corporation Information
    • 11.8.2 HCA Healthcare, Inc. Description and Business Overview
    • 11.8.3 HCA Healthcare, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Products Offered
    • 11.8.5 HCA Healthcare, Inc. Related Developments
  • 11.9 Alzeca Biosciences, Inc.
    • 11.9.1 Alzeca Biosciences, Inc. Corporation Information
    • 11.9.2 Alzeca Biosciences, Inc. Description and Business Overview
    • 11.9.3 Alzeca Biosciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Products Offered
    • 11.9.5 Alzeca Biosciences, Inc. Related Developments
  • 11.10 Johnson & Johnson
    • 11.10.1 Johnson & Johnson Corporation Information
    • 11.10.2 Johnson & Johnson Description and Business Overview
    • 11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Johnson & Johnson Helminthic Infestations Therapeutics Products Offered
    • 11.10.5 Johnson & Johnson Related Developments
  • 11.1 Neural Analytics, Inc.
    • 11.1.1 Neural Analytics, Inc. Corporation Information
    • 11.1.2 Neural Analytics, Inc. Description and Business Overview
    • 11.1.3 Neural Analytics, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Neural Analytics, Inc. Helminthic Infestations Therapeutics Products Offered
    • 11.1.5 Neural Analytics, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Helminthic Infestations Therapeutics Market Estimates and Projections by Region
    • 12.1.1 Global Helminthic Infestations Therapeutics Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Helminthic Infestations Therapeutics Revenue Forecast by Regions 2021-2026
  • 12.2 North America Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
    • 12.2.1 North America: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
    • 12.2.2 North America: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
    • 12.2.3 North America: Helminthic Infestations Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
    • 12.3.2 Europe: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Helminthic Infestations Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Helminthic Infestations Therapeutics Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Helminthic Infestations Therapeutics Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Helminthic Infestations Therapeutics Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Helminthic Infestations Therapeutics Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Helminthic Infestations Therapeutics Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Helminthic Infestations Therapeutics Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Helminthic Infestations Therapeutics Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Helminthic Infestations Therapeutics Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Helminthic Infestations Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Helminthic Infestations Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Helminthic Infestations Therapeutics market is segmented into
    Benzimidazole
    Pyrantel
    Piperazine Citrate
    Others

    Segment by Application, the Helminthic Infestations Therapeutics market is segmented into
    Enterobius vermicularis
    Taenia saginata
    Ascaris lumbricoides
    Trichuris trichiura
    Others

    Regional and Country-level Analysis
    The Helminthic Infestations Therapeutics market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Helminthic Infestations Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Helminthic Infestations Therapeutics Market Share Analysis
    Helminthic Infestations Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Helminthic Infestations Therapeutics business, the date to enter into the Helminthic Infestations Therapeutics market, Helminthic Infestations Therapeutics product introduction, recent developments, etc.

    The major vendors covered:
    Neural Analytics, Inc.
    M3 Biotechnology, Inc.
    Cerevance
    Mitochon Pharmaceuticals, Inc.
    Peptilogics
    Farmoquimica S/A
    biOasis Technologies, Inc.
    HCA Healthcare, Inc.
    Alzeca Biosciences, Inc.
    Johnson & Johnson

    Buy now